|
US4228669A
(en)
*
|
1978-07-03 |
1980-10-21 |
Kysor Industrial Corporation |
Double cylinder lock with key retention
|
|
US4254648A
(en)
*
|
1979-02-21 |
1981-03-10 |
Norris Industries, Inc. |
Inner locking cylinder with captive key
|
|
US4315420A
(en)
*
|
1980-04-11 |
1982-02-16 |
Oliver Ronald N |
Retained key double cylinder deadbolt
|
|
US4369642A
(en)
*
|
1981-03-25 |
1983-01-25 |
Norris Industries, Inc. |
Detained key assembly
|
|
US4698989A
(en)
*
|
1986-09-26 |
1987-10-13 |
Kwikset Corporation |
Double cylinder lock assembly
|
|
US4793166A
(en)
*
|
1986-12-12 |
1988-12-27 |
Marks George R |
Multi-use lock cylinder
|
|
US5269162A
(en)
*
|
1990-10-12 |
1993-12-14 |
Emhart Inc. |
Cylinder lock
|
|
US5193372A
(en)
*
|
1991-04-19 |
1993-03-16 |
Dom-Sicherheitstechnik Gmbh & Co Kg |
Lock cylinder
|
|
US5140843A
(en)
*
|
1992-01-27 |
1992-08-25 |
Krueger Owen A |
Lock conversion mechanism
|
|
US5372021A
(en)
*
|
1992-10-30 |
1994-12-13 |
Ideaz International, Inc. |
Key control device and method therefor
|
|
US6207371B1
(en)
|
1996-10-04 |
2001-03-27 |
Lexicon Genetics Incorporated |
Indexed library of cells containing genomic modifications and methods of making and utilizing the same
|
|
US6855545B1
(en)
|
1996-10-04 |
2005-02-15 |
Lexicon Genetics Inc. |
Indexed library of cells containing genomic modifications and methods of making and utilizing the same
|
|
US5955355A
(en)
*
|
1997-03-27 |
1999-09-21 |
Millennium Pharmaceuticals, Inc. |
Chromosome 18 marker
|
|
US5914394A
(en)
*
|
1997-03-27 |
1999-06-22 |
Millenium Pharmaceuticals, Inc. |
Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
|
|
US5939316A
(en)
*
|
1997-03-27 |
1999-08-17 |
Millennium Pharmaceuticals, Inc. |
Chromosome 18 marker
|
|
US5866412A
(en)
*
|
1997-03-27 |
1999-02-02 |
Millennium Pharmaceuticals, Inc. |
Chromosome 18 marker
|
|
US5878613A
(en)
*
|
1997-08-06 |
1999-03-09 |
Secure Concepts, Ltd. |
Key retaining lock box
|
|
US20020061522A1
(en)
|
2000-02-29 |
2002-05-23 |
Glucksmann Maria Alexandra |
1983, 52881, 2398, 45449, 50289, and 52872 novel G protein-coupled receptors and uses therefor
|
|
CA2394015C
(fr)
|
1999-12-20 |
2013-11-05 |
Immunex Corporation |
Recepteur tweak
|
|
US20080194022A1
(en)
*
|
2000-08-03 |
2008-08-14 |
Clarke Michael F |
Isolation and use of solid tumor stem cells
|
|
US8044259B2
(en)
|
2000-08-03 |
2011-10-25 |
The Regents Of The University Of Michigan |
Determining the capability of a test compound to affect solid tumor stem cells
|
|
US6984522B2
(en)
*
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
|
EP1197550A3
(fr)
*
|
2000-08-25 |
2002-11-20 |
Pfizer Products Inc. |
Méthodes et compositions pour diagnostiquer et traiter des troubles associés à l'angiogenèse
|
|
JP2003000268A
(ja)
|
2000-08-25 |
2003-01-07 |
Pfizer Prod Inc |
血管新生にかかわる疾患を診断および治療するための方法および組成物
|
|
US6729169B2
(en)
|
2001-03-27 |
2004-05-04 |
Randall L. Moore |
Dual cylinder deadbolt adjunct
|
|
US7229774B2
(en)
|
2001-08-02 |
2007-06-12 |
Regents Of The University Of Michigan |
Expression profile of prostate cancer
|
|
EP2354793B1
(fr)
|
2001-08-14 |
2016-06-22 |
Sentigen Biosciences, Inc. |
Acides nucléiques et protéines de gènes de récepteur odorant OR83B d'insectes et utilisations associées
|
|
CA2459183A1
(fr)
*
|
2001-08-27 |
2003-03-06 |
Tularik Inc. |
Oncogenes amplifies et leur implication dans le cancer
|
|
KR100942880B1
(ko)
|
2001-08-29 |
2010-02-17 |
제넨테크, 인크. |
유사분열촉진 활성을 가진 Bv8 핵산 및 폴리펩티드
|
|
AU2002356898A1
(en)
*
|
2001-11-15 |
2003-06-10 |
Tularik Inc. |
Gene amplification and overexpression in cancer
|
|
EP2002827A2
(fr)
|
2001-12-05 |
2008-12-17 |
The Baylor College Of Medicine |
Procédés et compositions pour contrôler la formation osseuse via la modulation d'un son sympathique
|
|
EP1455815A4
(fr)
|
2001-12-19 |
2006-11-02 |
Millennium Pharm Inc |
Membres de la famille des diacylglycerol-acyltransferases 2 (dgat2) et leurs utilisations
|
|
AU2002359697A1
(en)
*
|
2001-12-20 |
2003-07-09 |
Tularik Inc. |
Identification of an amplified gene and target for drug intervention
|
|
JP2005532036A
(ja)
|
2002-01-09 |
2005-10-27 |
理化学研究所 |
癌プロフィール
|
|
WO2003079982A2
(fr)
*
|
2002-03-19 |
2003-10-02 |
Tularik Inc. |
Amplification de genes en cas de cancer
|
|
WO2003094841A2
(fr)
*
|
2002-05-06 |
2003-11-20 |
Functional Genetics, Inc. |
Genes de mammifere impliques dans une resistance a la rapamycine et une genese tumorale : genes d'annexine xiii
|
|
ATE544865T1
(de)
|
2002-07-12 |
2012-02-15 |
Us Gov Health & Human Serv |
Assays für den zusammenbau von ebola-virus- nukleocapsiden
|
|
WO2004015063A2
(fr)
*
|
2002-08-07 |
2004-02-19 |
Tularik Inc. |
Amplification et surexpression d'oncogenes
|
|
WO2004035970A1
(fr)
*
|
2002-10-15 |
2004-04-29 |
Geoffrey David Miles |
Ameliorations apportees a des verrous
|
|
EP1570081A4
(fr)
*
|
2002-11-19 |
2006-05-31 |
Amgen Inc |
Genes amplifies impliques dans un cancer
|
|
EP2112229A3
(fr)
|
2002-11-25 |
2009-12-02 |
Sequenom, Inc. |
Procédés d'identification du risque du cancer du sein et traitements associés
|
|
CN102225194B
(zh)
|
2003-03-12 |
2014-07-16 |
健泰科生物技术公司 |
Bv8和/或EG-VEGF促进造血的用途
|
|
US20060019256A1
(en)
|
2003-06-09 |
2006-01-26 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
AU2004249193A1
(en)
*
|
2003-06-20 |
2004-12-29 |
Amgen Inc. |
Gene amplification and overexpression in cancer
|
|
AU2005209909B8
(en)
*
|
2004-02-03 |
2009-01-15 |
The Regents Of The University Of Michigan |
Compositions and methods for characterizing, regulating, diagnosing, and treating cancer
|
|
EP2341073A3
(fr)
|
2004-02-24 |
2011-12-14 |
The Government of The United States of America, as represented by the Secretary, Department of Health and Human Services, |
RAB9A, RAB11A, et modulateurs correspondants liés à une maladie infectieuse
|
|
WO2005115435A2
(fr)
*
|
2004-04-30 |
2005-12-08 |
Bas Medical, Inc. |
Methodes et compositions de lutte contre les maladies de la croissance foetale par modulation de la relaxine
|
|
US7858323B2
(en)
|
2004-06-09 |
2010-12-28 |
The Regents Of The University Of Michigan |
Phage microarray profiling of the humoral response to disease
|
|
AU2006259583A1
(en)
*
|
2005-06-13 |
2006-12-28 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
US20070099209A1
(en)
*
|
2005-06-13 |
2007-05-03 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
CA2622295C
(fr)
|
2005-09-12 |
2019-01-15 |
The Regents Of The University Of Michigan |
Fusion geniques recurrentes dans le cancer de la prostate
|
|
US9957569B2
(en)
*
|
2005-09-12 |
2018-05-01 |
The Regents Of The University Of Michigan |
Recurrent gene fusions in prostate cancer
|
|
WO2007047907A2
(fr)
*
|
2005-10-14 |
2007-04-26 |
The Regents Of The University Of Michigan |
Compositions de proteines dek et methodes d'utilisation de celles-ci
|
|
WO2007050554A2
(fr)
*
|
2005-10-25 |
2007-05-03 |
The Trustees Of Columbia University In The City Of New York |
Identification de composes modulant l'activite des proteines du domaine phb, et compositions obtenues a partir de ces composes
|
|
EP1945754B1
(fr)
*
|
2005-10-31 |
2014-07-23 |
The Regents Of The University Of Michigan |
Compositions et méthodes pour traiter et diagnostiquer un cancer
|
|
EP2500360B1
(fr)
|
2005-10-31 |
2015-08-05 |
Oncomed Pharmaceuticals, Inc. |
Compositions et procédés pour le diagnostic et le traitement du cancer
|
|
US7723477B2
(en)
|
2005-10-31 |
2010-05-25 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
|
|
WO2007056113A2
(fr)
*
|
2005-11-02 |
2007-05-18 |
Cylene Pharmaceuticals, Inc. |
Procedes de ciblage de sequences quadruplex
|
|
EP1984400B1
(fr)
|
2006-01-05 |
2012-11-28 |
Immune Disease Institute, Inc. |
Régulateurs de nfat
|
|
WO2008121102A2
(fr)
*
|
2006-02-21 |
2008-10-09 |
The Regents Of The University Of Michigan |
Traitement du cancer par un antagoniste de la voie de signalisation hedgehog
|
|
US8153369B2
(en)
|
2006-06-05 |
2012-04-10 |
Cancer Care Ontario |
Assessment of risk for colorectal cancer
|
|
US7572618B2
(en)
|
2006-06-30 |
2009-08-11 |
Bristol-Myers Squibb Company |
Polynucleotides encoding novel PCSK9 variants
|
|
US8978426B2
(en)
*
|
2006-11-07 |
2015-03-17 |
Pacific Lock Company |
Hidden shackle lock incorporating a “key-in-knob” (KiK) cylinder
|
|
EP2106439B1
(fr)
*
|
2007-01-24 |
2014-11-12 |
The Regents of the University of Michigan |
Compositions et procédés pour le traitement et le diagnostic du cancer du pancréas
|
|
AU2008222563A1
(en)
|
2007-03-05 |
2008-09-12 |
Cancer Care Ontario |
Assessment of risk for colorectal cancer
|
|
WO2009023059A2
(fr)
|
2007-06-01 |
2009-02-19 |
The Trustees Of Princeton University |
Traitement d'infections virales par modulation de voies métaboliques de cellules hôtes
|
|
ES2694018T3
(es)
|
2007-07-02 |
2018-12-17 |
Oncomed Pharmaceuticals, Inc. |
Composiciones y métodos para el tratamiento y el diagnóstico del cáncer
|
|
US9303291B2
(en)
*
|
2007-07-06 |
2016-04-05 |
The Regents Of The University Of Michigan |
MIPOL1-ETV1 gene rearrangements
|
|
CA2692441C
(fr)
|
2007-07-06 |
2020-01-21 |
The Regents Of The University Of Michigan |
Fusions de gene solute carrier family 45 member 3 (slc45a3) et d'un genede la famille ets dans le cancer de la prostate
|
|
US7895865B2
(en)
*
|
2007-08-15 |
2011-03-01 |
Medeco Security Locks, Inc. |
Cylinder lock assembly with a tailpiece rotationally coupled to the cylinder plug
|
|
US8586081B2
(en)
*
|
2007-09-20 |
2013-11-19 |
University Of Massachusetts |
Detoxified recombinant botulinum neurotoxin
|
|
WO2009114543A2
(fr)
*
|
2008-03-11 |
2009-09-17 |
Sequenom, Inc. |
Tests adn pour déterminer le sexe d'un bébé avant sa naissance
|
|
US8476013B2
(en)
|
2008-09-16 |
2013-07-02 |
Sequenom, Inc. |
Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
|
US8962247B2
(en)
|
2008-09-16 |
2015-02-24 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
|
|
EP2331136B1
(fr)
|
2008-09-26 |
2018-01-10 |
OncoMed Pharmaceuticals, Inc. |
Agents se liant aux récepteurs frizzled et leurs utilisations
|
|
ES2623128T3
(es)
|
2008-11-11 |
2017-07-10 |
The Regents Of The University Of Michigan |
Composiciones ANTI-CXCR1 y métodos
|
|
AU2010203517B2
(en)
|
2009-01-09 |
2012-08-16 |
The Regents Of The University Of Michigan |
Recurrent gene fusions in cancer
|
|
US9938582B2
(en)
*
|
2009-09-17 |
2018-04-10 |
The Regents Of The University Of Michigan |
Recurrent gene fusions in prostate cancer
|
|
DK2516680T3
(en)
|
2009-12-22 |
2016-05-02 |
Sequenom Inc |
Method and kits to identify aneuploidy
|
|
TWI535445B
(zh)
|
2010-01-12 |
2016-06-01 |
安可美德藥物股份有限公司 |
Wnt拮抗劑及治療和篩選方法
|
|
EP2548025A4
(fr)
*
|
2010-03-17 |
2013-09-25 |
Univ Michigan |
Utilisation d'épitopes de phage à des fins de profilage de la réponse immunitaire
|
|
CN102971337B
(zh)
|
2010-04-01 |
2016-09-21 |
昂考梅德药品有限公司 |
卷曲蛋白结合药剂及其应用
|
|
DE102010038105B4
(de)
*
|
2010-10-11 |
2012-05-24 |
André Haake |
Verfahren zur Kodierung eines Schlosses und Rohteil zur Durchführung dieses Verfahrens
|
|
US8945556B2
(en)
|
2010-11-19 |
2015-02-03 |
The Regents Of The University Of Michigan |
RAF gene fusions
|
|
WO2012149339A2
(fr)
|
2011-04-29 |
2012-11-01 |
Sequenom, Inc. |
Quantification d'une minorité d'espèces d'acide nucléique
|
|
US8474289B2
(en)
|
2011-11-28 |
2013-07-02 |
Southern Company Services, Inc. |
Locking systems
|
|
EP4155401A1
(fr)
|
2012-03-02 |
2023-03-29 |
Sequenom, Inc. |
Méthodes et procédés d'évaluation non invasive de variations génétiques
|
|
US10504613B2
(en)
|
2012-12-20 |
2019-12-10 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
|
US9920361B2
(en)
|
2012-05-21 |
2018-03-20 |
Sequenom, Inc. |
Methods and compositions for analyzing nucleic acid
|
|
US20140093873A1
(en)
|
2012-07-13 |
2014-04-03 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
|
WO2014072832A2
(fr)
|
2012-10-18 |
2014-05-15 |
Oslo Universitetstssykehus Hf |
Biomarqueurs pour le cancer du col de l'utérus
|
|
JP2015536933A
(ja)
|
2012-10-23 |
2015-12-24 |
オンコメッド ファーマシューティカルズ インコーポレイテッド |
Wnt経路結合剤を用いて神経内分泌腫瘍を処置する方法
|
|
CN105073195A
(zh)
|
2013-02-04 |
2015-11-18 |
昂科梅德制药有限公司 |
使用Wnt途径抑制剂进行治疗的方法及对该治疗的监测
|
|
EP3597774A1
(fr)
|
2013-03-13 |
2020-01-22 |
Sequenom, Inc. |
Amorces pour analyse de la méthylation de l'adn
|
|
US9168300B2
(en)
|
2013-03-14 |
2015-10-27 |
Oncomed Pharmaceuticals, Inc. |
MET-binding agents and uses thereof
|
|
US10107008B2
(en)
|
2013-09-15 |
2018-10-23 |
Pacific Lock Company |
Lock device
|
|
WO2015138774A1
(fr)
|
2014-03-13 |
2015-09-17 |
Sequenom, Inc. |
Méthodes et procédés d'évaluation non invasive de variations génétiques
|
|
US10047547B2
(en)
|
2015-05-20 |
2018-08-14 |
Pacific Lock Company |
Locking link
|
|
US12282014B2
(en)
|
2015-11-19 |
2025-04-22 |
Dana-Farber Cancer Institute, Inc. |
Methods of identifying compounds that interfere with ERG-driven misguidance of BAF complexes in TMPRSS2-ERG driven prostate cancers
|
|
US10619382B2
(en)
|
2016-02-29 |
2020-04-14 |
Pacific Lock Company |
Keyless lock system
|
|
USD930458S1
(en)
|
2016-09-30 |
2021-09-14 |
Pacific Lock Company |
Lock casing
|
|
EP3746124A4
(fr)
|
2018-01-30 |
2021-10-27 |
Foghorn Therapeutics Inc. |
Composés et leurs utilisations
|
|
US12473334B2
(en)
|
2018-10-17 |
2025-11-18 |
Dana-Farber Cancer Institute, Inc. |
SWI/SNF family chromatin remodeling complexes and uses thereof
|
|
US12509453B2
(en)
|
2019-01-29 |
2025-12-30 |
Foghorn Therapeutics Inc. |
BRM/BRG1 inhibitors and uses thereof
|
|
US12384776B2
(en)
|
2019-01-29 |
2025-08-12 |
Foghorn Therapeutics Inc. |
Compounds and uses thereof
|
|
WO2021155262A1
(fr)
|
2020-01-29 |
2021-08-05 |
Foghorn Therapeutics Inc. |
Composés et leurs utilisations
|
|
WO2021155264A1
(fr)
|
2020-01-29 |
2021-08-05 |
Foghorn Therapeutics Inc. |
Composés et leurs utilisations
|
|
US12383555B2
(en)
|
2020-05-20 |
2025-08-12 |
Foghorn Therapeutics Inc. |
Methods of treating cancers
|
|
US12606553B2
(en)
|
2021-03-09 |
2026-04-21 |
Foghorn Therapeutics Inc. |
Crystalline forms, compositions containing same, and methods of their use
|